europe-injectables-drug-delivery-market-industry
Published

December 2017

Europe Injectable Drug Delivery Technology Market - Growth, Trends and Forecasts (2017-2022)

Purchase Report
$3850
Single user license
$4000
Team license
$8250
Corporate license

Europe Injectable Drug Delivery Technology Market 

Injectable drug delivery is defined as introduction of a drug or drugs in the patient by using a delivery device. Injectable allow the transport of drugs formulated in liquid form, directly in the body. Even though, they may be designed to transport the drug to specific part of the body.  Such drug delivery technology by the use of injections is majorly segmented into devices and formulations. Based on product, the injectable drug delivery devices technologies market is further categorized into conventional injection devices, self-injection devices, and others (micro needles, Nano needles and blunt needle injections), while injectable drug delivery formulation technologies market is categorized into conventional drug delivery formulations and novel drug delivery formulations.

The Injectable Drug Delivery Market valued as a USD XX billion in 2016 market is expected to show a CAGR of about XX% and is expected to reach USD XX billion by the end of the year 2022.

Market Drivers

Increasing prevalence of Chronic Diseases

Increased Demand

Technological Advances

Market Restraints

Injuries and Infections

Recent Advancements

Regulatory Framework

Market Segmentation

The Market is basically segmented into four categories namely on the basis of formulation, devices, application and geographical basis. Based on formulation the market is segmented into categories which are Conventional drug delivery and Novel Drug Delivery. On the basis of devices the market is segmented into categories which are Conventional devices and self-injectable devices. On the basis of application the market can be segmented into categories like Oncology, Diabetes, Hep C and others, etc.

Some of the key players in the market are:

Alkermes, Genetech, Bend Research, QLT Inc., Endocyte, Crossjet, Apogee Technology, Pulmatrix, Medicago, Liquida Technologies Inc., UCB Group, Pearl Therapeutics.

Key Deliverables in the Study

Market Analysis for this market, With Region-Specific Assessments and competition analysis on the global and regional scale.

Market Definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their market share.

Identification and analysis of the macro and micro factors that affect the global lab-on-a-chip and microarrays market on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.

Related Topics:

North America Injectable Drug Delivery Technology Market- Growth, Trends and Forecasts (2017 - 2022)

Global Injectable Drug Delivery Technology Market- Growth, Trends and Forecasts (2017 - 2022)

RELATED REPORTS
No related reports available.
Purchase Report
$3850
Single user license
$4000
Team license
$8250
Corporate license
Our Clients Include View All

Looking to Customize Report?